Autopsy report · NCT01407679
Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years 8 months before it stopped.
- 7 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University Hospital Muenster
- Sponsor type
- University, hospital or other
- Conditions
- Lupus Erythematosus, Cutaneous
- Interventions
- Alitretinoin
- Participants
- 7
- Sites
- 3
- Countries
- Germany
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.